Bone Marrow Transplant for Multiple Myeloma: What Nigerian Adults Should Know

Multiple myeloma is a cancer of the plasma cells — the cells in your bone marrow that help fight infection. When someone you love is diagnosed, the first question is usually the same: what happens next?

For many patients, the answer eventually involves a bone marrow transplant, or more precisely, a stem cell transplant. If you are in Nigeria or elsewhere in West Africa, you may be wondering whether travelling to India for a multiple myeloma bone marrow transplant makes sense. This article walks you through what the procedure involves, who it is for, realistic costs, and what the journey looks like from start to discharge.

---

What Is a Bone Marrow Transplant for Multiple Myeloma?

The term “bone marrow transplant” is commonly used, but in multiple myeloma the actual procedure is called an autologous stem cell transplant (ASCT). It does not involve a donor.

Here is how it works:

Your doctors first collect your own stem cells from your blood, before high-dose chemotherapy begins. These cells are frozen and stored. Then you receive high-dose chemotherapy, which destroys the myeloma cells — but also wipes out your bone marrow. After that, your stored stem cells are returned through an IV. Over the following weeks, they travel to the bone marrow and begin rebuilding your immune system.

It is intense. But for eligible patients, published research shows that ASCT can produce deep remission in a significant proportion of cases, meaningfully extending progression-free survival. For many patients, it translates to several additional years of good quality life.

---

Who Is a Candidate for This Transplant?

Not every myeloma patient is offered a transplant right away. The decision depends on several factors:

Age and fitness — Most patients who receive ASCT are under 70 and in reasonably good overall health. The treatment is demanding, and the body needs to be able to recover. Multiple myeloma in adults is the primary indication; paediatric cases are rare and evaluated separately.

Response to initial treatment — Before transplant, patients usually go through induction chemotherapy. How well the myeloma responds to this first round helps determine whether a transplant is the right next step.

Kidney function and other organ health — Since chemotherapy at high doses is involved, the kidneys, liver, and heart need to be in adequate condition.

If your family member has been diagnosed with multiple myeloma and is in their 40s, 50s, or early 60s, there is a reasonable chance a transplant is part of their treatment roadmap. Your Indian oncology team will evaluate this thoroughly at the time of consultation.

---

Why Nigerian Families Choose India for This Treatment

India has become one of the most established destinations in the world for complex blood cancer treatments.

Experienced transplant programmes — Many Indian hospitals have been performing stem cell transplants for over two decades, with dedicated bone marrow transplant units and teams that handle international cases routinely.

Accreditation — Look for hospitals accredited by NABH (National Accreditation Board for Hospitals) or internationally by JCI. These are reliable markers of quality and process standards.

Support for overseas patients — Most large transplant centres have international patient teams that handle visa letters, airport transfers, accommodation coordination, and translation support. Language is rarely a barrier in these units.

Cost — This is often the deciding factor. The cost of an autologous stem cell transplant in India is a fraction of what it would cost in the United States, the UK, or even South Africa.

---

What Does the Treatment Timeline Look Like?

A bone marrow transplant for multiple myeloma is not a two-week trip. Most families underestimate how long the full journey takes.

Here is a realistic breakdown:

Consultation and evaluation — 1 week Blood tests, bone marrow biopsy review, imaging, cardiac evaluation, and a first meeting with the transplant team.

Induction chemotherapy (if not already completed) — 3–4 months Some patients complete this in Nigeria before travelling. If starting from the beginning in India, this phase takes time.

Stem cell harvesting — 1–2 weeks Stem cells are mobilised with injections, collected through apheresis, and frozen.

High-dose chemotherapy and transplant — 3–4 weeks This is the core phase. The patient is hospitalised throughout.

Recovery and monitoring — 4–6 weeks Discharge happens only when blood counts recover and the patient is stable.

Total time in India: approximately 3–5 months for a complete treatment journey from first consultation to discharge.

Plan for a caregiver to travel with the patient. This is not optional — it is medically and emotionally necessary, and hospitals expect it.

If you want to map out a realistic timeline based on where the patient is in their treatment right now, send us a message on WhatsApp with their reports and we will walk you through it.

---

Bone Marrow Transplant Cost in India for Nigerian Patients

Costs vary depending on the hospital, city, and individual patient complexity. A transplant in Mumbai or Delhi at a large private hospital may cost more than the same procedure in Chennai or Hyderabad, not because of quality differences, but because of operational and infrastructure costs. A patient with complications or co-existing conditions may also require longer stays or additional medications.

These are honest general ranges:

What Is Covered	Approximate Cost (USD)
Pre-transplant evaluation	$500 – $1,500
Stem cell harvesting	$3,000 – $6,000
Transplant procedure + hospital stay	$18,000 – $30,000
Post-transplant monitoring and discharge	Included in most packages
Total estimated range	$22,000 – $40,000

These figures do not include flights, accommodation for the caregiver, or medications after discharge. Budget an additional $5,000 – $10,000 for those.

For a personalised estimate based on the patient’s specific reports, share the medical records with us on WhatsApp. We will coordinate with the hospital and respond within 24–48 hours.

---

What to Bring When You Travel

Organising the right documents before departure saves time at the hospital and helps the team prepare:

• All previous medical records: diagnosis, pathology, bone marrow biopsy, full blood test history
• Imaging: PET-CT scan, MRI, X-rays if available
• List of current medications
• Travel insurance documents
• Medical visa letter (provided by the hospital on request)

---

Frequently Asked Questions

Is a bone marrow transplant a cure for multiple myeloma?

An autologous stem cell transplant does not cure multiple myeloma in most cases. It deepens the remission — pushing the disease to a very low level — and extends the period before it returns. Many patients maintain good quality of life for several years after the procedure.

What happens if the myeloma comes back after transplant?

This is called relapse, and it is common. It does not mean treatment is over. Maintenance therapy, a second transplant, or newer drug combinations may all be options depending on the situation.

Can Nigerian patients get a visa to India for medical treatment?

Yes. India offers a Medical Visa specifically for international patients. The hospital provides a letter of recommendation, and the visa is generally processed within a few days. The caregiver can apply for a Medical Attendant Visa at the same time.

How many rounds of chemotherapy are needed before the transplant?

Most patients receive 4–6 cycles of induction chemotherapy before being assessed for transplant. The goal is to reduce the myeloma burden as much as possible first.

Will the patient feel unwell during the transplant phase?

Yes. High-dose chemotherapy causes fatigue, nausea, mouth sores, and reduced immunity. This is expected and managed closely by the transplant team. Recovery is gradual — blood counts usually begin rising 2–3 weeks after the stem cells are infused.

Can I get a second opinion before committing to treatment in India?

Yes, and many families do this first. If you already have reports from a local oncologist in Nigeria, the Indian team can review them remotely and give you an opinion before any decisions are made. Reach out on WhatsApp and we will connect you with the right specialist.

What is the difference between autologous and allogeneic transplant?

In an autologous transplant, the patient is their own donor. In an allogeneic transplant, cells come from a matched sibling or unrelated donor. For multiple myeloma, the autologous approach is the standard. Allogeneic transplants are more complex and used in specific situations.

---

Making the Decision

Deciding to travel abroad for a bone marrow transplant is not easy. There is the cost, the distance, the uncertainty. Most families who reach out to us are not looking for someone to make the decision for them. They want honest information and a sense that someone understands what they are going through.

If you are at the point of gathering information — not yet ready to book, just trying to understand what is involved — that is the right place to start. Send us whatever you have on WhatsApp: a diagnosis report, a recommendation from a doctor, or just a question. We will respond, and we will be straightforward with you.

The path through multiple myeloma is long. The right treatment, in the right hands, can make a real difference.